Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Shaharabani

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Transplantation Proceedings|March 20, 2003
Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipientsZ Ben-Ari, E Mor, N Bar-Nathan, et al.
Transplantation Proceedings|March 20, 2003
Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantationZ Ben-Ari, E Mor, N Bar-Nathan, et al.
Transplantation Proceedings|June 17, 2000
Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantationZ Ben-Ari, E Mor, E Shaharabani, et al.
Transplantation Proceedings|February 1, 1989
Post-transplant glomerulonephritis under conventional and cyclosporin A immunosuppressionA Yussim, M Ben-Bassat, Z Shapira, et al.
Transplantation|October 17, 2001
Defibrotide for the treatment of veno-occlusive disease after liver transplantationE Mor, O Pappo, N Bar-Nathan, et al.
Transplantation Proceedings|August 1, 1994
OKT3 for steroid-resistant renal allograft rejection: differential response in adults and childrenD Shmueli, R Nakache, S Lustig, et al.
Transplantation Proceedings|September 18, 1997
Beneficial effect of lamivudine pre- and post-liver transplantation for hepatitis B infectionZ Ben-Ari, D Shmueli, E Mor, et al.
Transplantation Proceedings|June 17, 2000
Lack of correlation between HLA match and long-term survival in living donor kidney transplantationT Klein, Z Shapira, N Bar Nathan, et al.
Transplantation Proceedings|August 1, 1994
Renal transplant from live donors over 65 years oldD Shmueli, R Nakache, S Lustig, et al.
Transplantation Proceedings|October 1, 1994
Gastrointestinal, hepatorenal, and neuromuscular toxicity caused by cyclosporine-colchicine interaction in renal transplantationA Yussim, N Bar-Nathan, S Lustig, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Transplantation Proceedings|March 20, 2003
Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipientsZ Ben-Ari, E Mor, N Bar-Nathan, et al.
Transplantation Proceedings|March 20, 2003
Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantationZ Ben-Ari, E Mor, N Bar-Nathan, et al.
Transplantation Proceedings|June 17, 2000
Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantationZ Ben-Ari, E Mor, E Shaharabani, et al.
Transplantation Proceedings|February 1, 1989
Post-transplant glomerulonephritis under conventional and cyclosporin A immunosuppressionA Yussim, M Ben-Bassat, Z Shapira, et al.
Transplantation|October 17, 2001
Defibrotide for the treatment of veno-occlusive disease after liver transplantationE Mor, O Pappo, N Bar-Nathan, et al.
Transplantation Proceedings|August 1, 1994
OKT3 for steroid-resistant renal allograft rejection: differential response in adults and childrenD Shmueli, R Nakache, S Lustig, et al.
Transplantation Proceedings|September 18, 1997
Beneficial effect of lamivudine pre- and post-liver transplantation for hepatitis B infectionZ Ben-Ari, D Shmueli, E Mor, et al.
Transplantation Proceedings|June 17, 2000
Lack of correlation between HLA match and long-term survival in living donor kidney transplantationT Klein, Z Shapira, N Bar Nathan, et al.
Transplantation Proceedings|August 1, 1994
Renal transplant from live donors over 65 years oldD Shmueli, R Nakache, S Lustig, et al.
Transplantation Proceedings|October 1, 1994
Gastrointestinal, hepatorenal, and neuromuscular toxicity caused by cyclosporine-colchicine interaction in renal transplantationA Yussim, N Bar-Nathan, S Lustig, et al.
Pageof 5